Trials / Completed
CompletedNCT01335581
Study of Laser Treatment of Melasma
A Study of the RevLite Q-Switched Nd:YAG Laser System With Smart Infinite (SI) Handpiece for the Treatment of Refractory Mixed Type Melasma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- ConBio, a Cynosure Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the RevLite laser in the treatment of refractory mixed type melasma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Q-Switched Nd:YAG Laser (RevLite) | Laser treatment added to a microdermabrasion and topical lightening agent regimen |
| DRUG | Retin-A and microdermabrasion | Microdermabrasion and topical lightening agent regimen |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2011-04-14
- Last updated
- 2022-01-13
- Results posted
- 2020-12-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01335581. Inclusion in this directory is not an endorsement.